Kairax™ Sub Q – Deep Volumetric Restoration for Advanced Contouring

At Aesthetics Pharma Shop, we select products that demonstrate clinical superiority and predictable outcomes. Kairax™ Sub Q represents the pinnacle of the Kairax portfolio—a high-density, biphasic hyaluronic acid filler engineered specifically for the most demanding deep augmentation procedures.

Unlike monophasic fillers that exhibit uniform consistency, Kairax™ Sub Q utilizes biphasic technology, combining cross-linked HA particles suspended in a non-cross-linked HA carrier. This unique rheological profile provides exceptional lifting capacity, precise mouldability, and sustained durability while maintaining natural tissue integration.

Designed for the advanced practitioner, Kairax™ Sub Q delivers correction of severe contour deficiencies with confidence and consistency.

🔬 Product Ingredient

Active Substance:

• Cross-linked Hyaluronic Acid (HA) – 24 mg/ml

• Biphasic Technology:

  • Cross-linked HA particles (80%)

  • Non-cross-linked HA carrier (20%)

  • Particle size optimized for deep tissue support

• Non-animal, bacterial fermentation-derived

• BDDE cross-linked with residual levels below 2 ppm

• High elastic modulus (G’) for superior lift

Concentration Advantage:

• 24 mg/ml HA concentration – Higher than industry standard (20 mg/ml)

• Provides enhanced volumisation per millilitre

• Extended durability through high cross-linking density

Presentation:

• Sterile, ready-to-use 1ml pre-filled syringe

• 26G ultra-thin needle included

• European compliant labelling with full batch traceability

• Cold chain maintained through delivery

✅ Effectiveness

Kairax™ Sub Q is clinically indicated for severe to very severe contour deficiencies and age-related volume depletion. It is the product of choice when maximum projection and longevity are required.

Duration: Clinical evidence demonstrates persistence of 12 to 18 months, with many patients retaining visible correction beyond 18 months. The biphasic particle structure resists enzymatic degradation more effectively than monophasic alternatives.

Aesthetic Outcome: Patients achieve dramatic, visible restoration of youthful facial proportions. The high G’ provides genuine skeletal support, recreating the structural foundation of the youthful face rather than simply filling soft tissue.

💉 Usage (For Professional Use Only)

Injection Depth:

• Deep subcutaneous tissue

• Supraperiosteal (bone surface)

• Not indicated for mid-dermal or superficial injection

Technique:

Cannula Compatibility:

• Fully compatible with 22G or 25G blunt cannulas

• Reduces trauma, bruising, and patient downtime

• Recommended for jawline and temple contouring

Biphasic Handling Note:

• Do not over-massage – Biphasic fillers require gentler moulding than monophasic gels

• Allow 2–3 minutes for particle integration with surrounding tissues

• Ice application before, not after, moulding

Post-Treatment:

• Significant oedema expected; peaks at 48–72 hours

• Cold compress protocol essential

• Arnica/bromelain recommended for bruise-prone patients

• Avoid dental procedures for 2 weeks following chin/jaw treatment

• Avoid pressure on treated areas during sleep

For licensed medical professionals only. Contraindicated in patients with severe hypersensitivity to hyaluronic acid. Not indicated for superficial injection, lip augmentation, or periocular use.

❓ Why Use Kairax™ Sub Q?

1. True Skeletal Support
   Kairax™ Sub Q is not a “soft tissue filler”—it is a structural implant in injectable form. The biphasic particle technology provides the elastic modulus necessary to resist the compressive forces of facial musculature and soft tissue. This is genuine lifting capacity, not passive displacement.

2. 24 mg/ml Concentration Advantage
   At 24 mg/ml HA concentration, Kairax™ Sub Q delivers 20% more cross-linked hyaluronic acid than standard 20 mg/ml fillers. This translates to:

   • Greater projection per millilitre

   • Extended durability

   • Reduced number of syringes per treatment

   • Superior cost-efficiency for clinics and patients

3. Biphasic Precision
   The biphasic structure allows for controlled placement and predictable integration. Unlike monophasic fillers that can migrate or disperse, the cross-linked particles remain precisely where placed, while the HA carrier facilitates smooth injection and tissue acceptance.

4. Severe Indication Authority
   Kairax™ Sub Q is indicated for severe to very severe contour deficiencies—a classification many fillers avoid. This positions it as the specialist’s choice for complex reconstructive and advanced aesthetic cases.

5. European Manufacturing Compliance
   Manufactured in GMP-certified facilities with full EU regulatory compliance, Kairax™ Sub Q meets the stringent standards required by hospital procurement departments and accredited aesthetic clinics.

6. Portfolio Synergy
   Within the Kairax portfolio, Sub Q functions as the foundation layer. Protocol recommendation:

   • Kairax™ Sub Q – Deep structural support

   • Kairax™ Deep – Moderate volumetric correction

   • Kairax™ Fine – Superficial refinement and skin quality

7. Authenticity Guaranteed
   Every Kairax™ Sub Q syringe supplied by Aesthetics Pharma Shop is sourced through authorised European distribution channels, cold chain maintained, and verified for full batch traceability. We provide comprehensive documentation for your clinical governance requirements.

Product Portfolio Positioning:

Kairax™ Sub Q should be positioned as the apex product within the Kairax range. Create a clear hierarchy: